Binger Straße 173

D-55216 Ingelheim



Project leader

Dr. Ralf Heilker
Lead Identification
Phone +49 7351 54 5590
Fax +49 7351 83 5590

Co-Project leader

Dr. Mario Beilmann
Nonclinical Drug Safety
88397 Biberach an der Riss
Phone +49 7351 547726
Fax +49 7351 54 98686


Project staff

Prof. Bastian Hengerer
CNS Diseases Research
Phone +49 7351 54 4742
Fax +49 7351 83 4742


Prof. Frank Gillardon
CNS Diseases Research
Phone +49 7351 54 8460
Fax +49 7351 83 8460


Dr. Tobias Hildebrandt
Target Discovery Research
Phone +49 7351 54 547819
Fax +49 7351 54 547819


Dr. Florian Meier
Toxicology & Assay development
Phone +49 7351 54 143219


Dr. Rolf Göggel

Research Networking
88397 Biberach an der Riss


Phone +49 7351 54 96889
Fax +49 7351 54 5997


Institute presentation

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Research & development has been the foundation of Boehringer Ingelheim's success and continues to be the major driver of innovative, new medicines for the treatment of diseases with high unmet medical need. Furthermore, in our constant quest for pharmaceutical innovation we have successful ongoing collaborations and are actively seeking new collaborations with external partners, ranging from academic institutions to biopharmaceutical enterprises and start-up companies.

Boehringer Ingelheim's successes in research & development continuously strengthen our portfolio of medications and offer patients true therapeutic benefit. The company focuses on six major research areas: CardioMetabolic diseases, Central nervous system diseases, Immunology and Inflammation, Infectious diseases, Oncology and Respiratory diseases.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline